Yokohama City University Medical Center, Center of IBD

Yokohama 232-0024

1 studies enrolling now · 2 studies all time

What they study most

Crohn's Disease, Ulcerative Colitis

Studies at this site

• A Study of Mirikizumab (LY3074828) in Pediatric Participants With Crohn's Disease — Recruiting now
• A Study of Mirikizumab (LY3074828) in Pediatric Participants With Moderately to Severely or Active Ulcerative Colitis — Completed